AMC Entertainment shares are trading flat Wednesday afternoon as investors await the company's third-quarter earnings report.

Amgen remains a compelling long-term buy, supported by robust R&D investment and a promising drug pipeline for future growth.

AMD shares ($AMD) get a new forecast after 5-star UBS analyst Timothy Arcuri raised its price target to $300 from $265, ...